Resoundant is a global leader in medical imaging technology, specializing in Magnetic Resonance Elastography (MRE). Their FDA-cleared upgrade for MRI systems allows for the noninvasive measurement of tissue stiffness, particularly for liver fibrosis staging, offering a painless and cost-effective alternative to needle biopsy.
With thousands of leading radiology and imaging centers worldwide offering MR Elastography, Resoundant's innovative technology is widely accessible for liver fibrosis assessment, providing a comprehensive picture of the condition. Their commitment to advancing the field is evident through their research, clinical trial services, and continuous development of cutting-edge solutions.
Generated from the website